Affdal AO, Moutard ML, Billette de Villemeur T, Duchange N, Hervé C, Moutel G. [A difficult transition from childhood to adult healthcare: the case of epilepsy]. [Article in French] Arch Pediatr. 2015 Apr;22(4):337-42. IF:0.407
———————————————————————————————————————————————————
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; CONCORD Working Group. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015 Mar 14;385(9972):977-1010. IF:45.217
———————————————————————————————————————————————————
Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, Holleczek B, Johnston BT, Cook MB, Bannon F, Sant M; EUROCARE-5 Working Group. Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: results from EUROCARE-5. Eur J Cancer. 2015 Sep 5. pii: S0959-8049(15)00706-6. IF:5.417
———————————————————————————————————————————————————
Asamura H, Chansky K, Crowley J, Goldstraw P, Rusch VW, Vansteenkiste JF, Watanabe H, Wu YL, Zielinski M, Ball D, Rami-Porta R; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members, and Participating Institutions. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2015 Dec;10(12):1675-84. IF:5.282
———————————————————————————————————————————————————
Baili P, Di Salvo F, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, Micheli A, Lillini R, Francisci S; EUROCARE-5 Working Group. Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study. Eur J Cancer. 2015 Sep 6. pii: S0959-8049(15)00705-4. IF:5.417
———————————————————————————————————————————————————
Baldi I, Carles C, Blanc-Lapierre A, Fabbro-Peray P, Druet-Cabanac M, Boutet-Robinet E, Soulat JM, Bouvier G, Lebailly P; PESTIMAT Group. A French crop-exposure matrix for use in epidemiological studies on pesticides: PESTIMAT. J Expo Sci Environ Epidemiol. 2015 Dec 23. doi: 10.1038/jes.2015.72. [Epub ahead of print] IF:3.185
———————————————————————————————————————————————————
Bardet S, Ciappuccini R, Quak E, Rame JP, Blanchard D, de Raucourt D, Babin E, Michels JJ, Vaur D, Heutte N. Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancer. J Clin Endocrinol Metab. 2015 Jan;100(1):132-40. IF : 6.209
———————————————————————————————————————————————————
Barrellier MT, Nativelle S, Lacaze E, Morello R, Le Hello C. [Analysis of the anatomical sites of 172 lower-limb venous thromboses occurring in a hormonal context in 996 young women; impact of the duplex-Doppler exploration]. [Article in French]J Mal Vasc. 2015 Mar 17. pii: S0398-0499(15)00076-1. IF:0.24
———————————————————————————————————————————————————
Barillet M, Prevost V, Joly F, Clarisse B. Oral antineoplastic agents: how do we care about adherence? Br J Clin Pharmacol. 2015 Dec;80(6):1289-302. IF:3.878
———————————————————————————————————————————————————
Barthelemy A, Lobbedez T, Bechade C, Henri P, Batho JM, Cardineau E, Jeanson A, Landru I, Lefort F, Potier J, Zagdoun E, Thibon P. Hemodialysis in satellite dialysis units: incidence of patient fallback to the in-center dialysis unit. J Nephrol. 2015 Aug;28(4):485-93. IF:1.454
———————————————————————————————————————————————————
Béchade C, Lobbedez T; Pour la Commission d’épidémiologie et de santé publique de la Société de néphrologie. [Dealing with competing events in survival analysis]. [Article in French] Nephrol Ther. 2015 Apr;11(2):69-72. IF : 2.083
———————————————————————————————————————————————————
Béchade C, Lobbedez T, Ivarsen P, Povlsen JV. Assisted Peritoneal Dialysis for Older People with End-Stage Renal Disease: The French and Danish Experience. Perit Dial Int. 2015 Nov;35(6):663-6. IF:1.527
———————————————————————————————————————————————————
Béchade C, Goovaerts T, Cougnet P, Labriola L, Jadoul M, Goffin E. Buttonhole Cannulation Is Not Associated with More AVF Infections in a Low-Care Satellite Dialysis Unit: A Long-Term Longitudinal Study. PLoS One. 2015 Nov 17;10(11):e0142256. IF:3.234
———————————————————————————————————————————————————
Bensefa-Colas L, Telle-Lamberton M, Faye S, Bourrain JL, Crépy MN, Lasfargues G, Choudat D; RNV3P members, Momas I. Occupational contact urticaria: lessons from the French National Network for Occupational Disease Vigilance and Prevention (RNV3P) Br J Dermatol. 2015 Dec;173(6):1453-61. IF:4.275
———————————————————————————————————————————————————
Benarous L, Terrier B, Puéchal X, Dunogué B, Cohen P, Le Jeunne C, Mouthon L, Guillevin L; French Vasculitis Study Group (FVSG). Tobacco differentially affects the clinical-biological phenotypes of ANCA-associated vasculitides. Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-116-21. IF: 2.724
———————————————————————————————————————————————————
Bon-Mardion N, De Raucourt D, Babin E, Rame JP, Dehesdin D, Choussy O. Cervical lymph node metastases and T1 squamous cell carcinoma of the lips. B-ENT. 2015;11(2):89-93. IF:0.431
———————————————————————————————————————————————————
Bouhnik AD, Bendiane MK, Cortaredona S, Sagaon Teyssier L, Rey D, Berenger C, Seror V, Peretti-Watel P; members of VICAN Group. The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey). BMJ Open. 2015 Mar 24;5(3):e005971. IF:2.271
———————————————————————————————————————————————————
Bouillet T, Bigard X, Brami C, Chouahnia K, Copel L, Dauchy S, Delcambre C, Descotes JM, Joly F, Lepeu G, Marre A, Scotte F, Spano JP, Vanlemmens L, Zelek L. Role of physical activity and sport in oncology: Scientific commission of the National Federation Sport and Cancer CAMI. Crit Rev Oncol Hematol. 2015 Apr;94(1):74-86. IF:4.027
———————————————————————————————————————————————————
Boulanger M, Bienvenu B, Marquignon MF, Letourneux M, Clin B. [Systemic sclerosis and occupational exposures: About a case in a driller-powderman]. [Article in French] Rev Med Interne. 2015 Aug;36(8):551-4. IF:1.074
———————————————————————————————————————————————————
Boulanger M, Morlais F, Bouvier V, Galateau-Salle F, Guittet L, Marquignon MF, Paris C, Raffaelli C, Launoy G, Clin B. Digestive cancers and occupational asbestos exposure: incidence study in a cohort of asbestos plant workers. Occup Environ Med. 2015 Nov;72(11):792-7. IF:1.63
———————————————————————————————————————————————————
Bouhnik AD, Bendiane MK, Cortaredona S, Sagaon Teyssier L, Rey D, Berenger C, Seror V, Peretti-Watel P; members of VICAN Group. The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey). BMJ Open. 2015 Mar 24;5(3):e005971.
———————————————————————————————————————————————————
Bouvier AM, Launoy G. [Epidemiology of colorectal cancer]. [Article in French] Rev Prat. 2015 Jun;65(6):767-73.
———————————————————————————————————————————————————
Bouvier AM, Launoy G, Bouvier V, Rollot F, Manfredi S, Faivre J, Cottet V, Jooste V. Incidence and patterns of late recurrences in colon cancer patients. Int J Cancer. 2015 Nov 1;137(9):2133-8. IF:5.085
———————————————————————————————————————————————————
Brosseau S, Oulkhouir Y, Naltet C, Zalcman G. [Resistances to targeted therapies and strategy for following therapeutic lines in metastatic NSCLC]. [Article in French] Bull Cancer. 2015 Jun;102(6 Suppl 1):S27-33.IF:0.604
———————————————————————————————————————————————————
Bruey N, Reinbold D, Creveuil C, Dreyfus M. [Preterm breech before 35 weeks of gestation: What is the influence of the delivery route on neonatal condition?]. [Article in French] Gynecol Obstet Fertil. 2015 Nov;43(11):699-704. IF:0.522
———————————————————————————————————————————————————
Bryere J, Pornet C, Dejardin O, Launay L, Guittet L, Launoy G. Correction of misclassification bias induced by the residential mobility in studies examining the link between socioeconomic environment and cancer incidence. Cancer Epidemiol. 2015 Jan 8. IF:2.711
———————————————————————————————————————————————————
Bylicki O, Gan HK, Joly F, Maillet D, You B, Péron J. Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy. Ann Oncol. 2015 Jan;26(1):231-7. IF:7.04
———————————————————————————————————————————————————
Cadranel J, Gervais R, Merle P, Moro-Sibilot D, Westeel V, Bigay-Game L, Quoix E, Friard S, Barlesi F, Lethrosne C, Moreau L, Monnet I, Salaun M, Oliviero G, Souquet PJ, Antoine M, Langlais A, Morin F, Wislez M, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique (IFCT). Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504. Eur Respir J. 2015 Nov;46(5):1440-50. IF:7.636
———————————————————————————————————————————————————
Chantepie SP, Mear JB, Guittet L, Dervaux B, Marolleau JP, Jardin F, Dutheil JJ, Parienti JJ, Vilque JP, Reman O. Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trial. Trials. 2015 Nov 23;16:533. IF:1.731
———————————————————————————————————————————————————
Chausserie S, Levillain R, Puvinel J, Ferrand O, Ruiz A, Raginel T, Lantieri O, Launoy G, Guittet L. Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screeningInt J Cancer. 2015 Apr 15;136(8):1827-34. IF:5.085
———————————————————————————————————————————————————
Choueiri TK, Escudier B, Powles T, Mainwaring PN, Rini BI, Donskov F, Hammers H, Hutson TE, Lee JL, Peltola K, Roth BJ, Bjarnason GA, Géczi L, Keam B, Maroto P, Heng DY, Schmidinger M, Kantoff PW, Borgman-Hagey A, Hessel C, Scheffold C, Schwab GM, Tannir NM, Motzer RJ; METEOR Investigators. Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma. N Engl J Med. 2015 Nov 5;373(19):1814-23. IF:55.873
———————————————————————————————————————————————————
Christophe V, Duprez C, Congard A, Antoine P, Lesur A, Fournier E, Vanlemmens L. The subjective experience of young women with non-metastatic breast cancer: the Young Women with Breast Cancer Inventory. Health Qual Life Outcomes. 2015 Jun 3;13:73.
———————————————————————————————————————————————————
Ciappuccini R, Aide N, Métayer L, Bardet S. Unusual 131Iodine uptake in a joint demonstrated by SPECT/CT in a patient with differentiated thyroid cancer. Clin Nucl Med. 2015 Apr;40(4):332-4.
———————————————————————————————————————————————————
Clanet R, Bansard M, Humbert X, Marie V, Raginel T. [Systematic review of hospital discharge summaries and general practitioners' wishes]. [Article in French] Sante Publique. 2015 Sep-Oct;27(5):701-11.
———————————————————————————————————————————————————
Colonna M, Uhry Z, Guizard AV, Delafosse P, Schvartz C, Belot A, Grosclaude P; FRANCIM network. Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France. Cancer Epidemiol. 2015 Aug;39(4):511-8. IF:2.711
———————————————————————————————————————————————————
Corvol A, Moutel G, Somme D. What ethics for case managers? Literature review and discussion. Nurs Ethics. 2015 Jun 1. pii: 0969733015583182. [Epub ahead of print] IF:1.247
———————————————————————————————————————————————————
Cottet V, Bouvier V, Rollot F, Jooste V, Bedenne L, Faivre J, Launoy G, Bouvier AM. Incidence and patterns of late recurrences in rectal cancer patients. Ann Surg Oncol. 2015 Feb;22(2):520-7.IF:3.93
———————————————————————————————————————————————————
Couraud S, Debieuvre D, Moreau L, Dumont P, Margery J, Quoix E, Duvert B, Cellerin L, Baize N, Taviot B, Coudurier M, Cadranel J, Missy P, Morin F, Mornex JF, Zalcman G, Souquet PJ; on behalf of the BioCAST/IFCT-1002 study investigators. No impact of passive smoke on the somatic profile of lung cancers in never-smokers. Eur Respir J. 2015 Mar 5. IF:7.636
———————————————————————————————————————————————————
Couraud S, Souquet PJ, Paris C, Dô P, Doubre H, Pichon E, Dixmier A, Monnet I, Etienne-Mastroianni B, Vincent M, Trédaniel J, Perrichon M, Foucher P, Coudert B, Moro-Sibilot D, Dansin E, Labonne S, Missy P, Morin F, Blanché H, Zalcman G; on behalf of The French Cooperative Intergroup IFCT. BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers. Eur Respir J. 2015 Feb 5. IF:7.636
———————————————————————————————————————————————————
Cuny F, Meunier A, Heutte N, Rame JP, De Raucourt D, Babin E, Blanchard D. Laryngeal preservation in ENT oncology. Retrospective series of 246 patients managed in the Caen University Hospital and François Baclesse Cancer Care Center between 1998 and 2008. Eur Ann Otorhinolaryngol Head Neck Dis. 2015 Mar 30. pii: S1879-7296(15)00032-0. IF:0.822
———————————————————————————————————————————————————
De Cock L, Kieffer A, Kurtz JE, Joly F, Weber B. [Expectations of patients with ovarian cancer. Results of the European investigation EXPRESSION III in French patients from GINECO group.] [Article in French]. Bull Cancer. 2015 Mar 5. pii: S0007-4551(15)00071-5. IF:0.604
———————————————————————————————————————————————————
De Angelis R, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, Visser O, Maynadié M, Marcos-Gragera R, Troussard X, Agius D, Roazzi P, Meneghini E, Monnereau A; EUROCARE-5 Working Group. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study. Eur J Cancer. 2015 Sep 6. pii: S0959-8049(15)00778-9. IF:5.417
———————————————————————————————————————————————————
de la Rochefordiere A, Kamal M, Floquet A, Thomas L, Petrow P, Petit T, Pop M, Fabbro M, Kerr C, Joly F, Sevin E, Maillard S, Curé H, Weber B, Brunaud C, Minsat M, Gonzague L, Berton-Rigaud D, Aumont M, Gladieff L, Peigneux K, Bernard V, Leroy Q, Bieche I, Margogne A, Nadan AT, Fourchotte V, Diallo A, Asselain B, Plancher C, Armanet S, Beuzeboc P, Scholl S. PIK3CA pathway mutations predictive of poor response following Standard radio chemotherapy +/- Cetuximab in cervical cancer patients. Clin Cancer Res. 2015 Feb 27. IF:8.722
———————————————————————————————————————————————————
Deneuve S, Babin E, Lacau-St-Guily J, Baujat B, Bensadoun RJ, Bozec A, Chevalier D, Choussy O, Cuny F, Fakhry N, Guigay J, Makeieff M, Merol JC, Mouawad F, Pavillet J, Rebiere C, Righini CA, Sostras MC, Tournaille M, Vergez S. Guidelines (short version) of the French Otorhinolaryngology – Head and Neck Surgery Society (SFORL) on patient pathway organization in ENT: The therapeutic decision-making process. Eur Ann Otorhinolaryngol Head Neck Dis. 2015 Sep;132(4):213-5 IF:0.822
———————————————————————————————————————————————————
Denoual-Ziad C, Aicardi-Nicolas S, Creveuil C, Gaillard C, Dreyfus M, Benoist G. Impact of prolonged dinoprostone cervical ripening on the rate of artificial induction of labor: A prospective study of 330 patients. J Obstet Gynaecol Res. 2015 Mar;41(3):370-6. IF:1.072
———————————————————————————————————————————————————
Deshayes S, Galateau-Sallé F, de La Blanchardière A. [Hepatic abnormality]. [Article in French] Rev Med Interne. 2015 May;36(5):363-4. IF:1.323
———————————————————————————————————————————————————
Dollfus S, Mach C, Morello R. Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms. Schizophr Bull. 2015 Nov 12. pii: sbv161. [Epub ahead of print] IF:8.45
———————————————————————————————————————————————————
Duquennoy S, Bechade C, Verger C, Ficheux M, Ryckelynck JP, Lobbedez T. Is peritonitis risk increased in elderly patients on peritoneal dialysis? report from the french language peritoneal dialysis registry (rdplf). Perit Dial Int. 2015 Dec 3. pii: pdi.2014.00154. [Epub ahead of print] IF:1.527
———————————————————————————————————————————————————
Eberhardt WE, Mitchell A, Crowley J, Kondo H, Kim YT, , Goldstraw P, Rami-Porta R; International Association for Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members, and Participating Institutions The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2015 Nov;10(11):1515-22.
———————————————————————————————————————————————————
Fakhry N, Vergez S, Baumstarck K, Lagier A, Santini L, Dessi P, Babin E, Giovanni A. Multicentric evaluation of strategies for treatment of T1a glottic carcinomas. Eur Arch Otorhinolaryngol. 2015 Jan;272(1):143-8. IF:1.545
———————————————————————————————————————————————————
Fakhry N, Vergez S, Babin E, Baumstarck K, Santini L, Dessi P, Giovanni A. Management of surgical margins after endoscopic laser surgery for early glottic cancers: a multicentric evaluation in French-speaking European countries. Eur Arch Otorhinolaryngol. 2015 Feb 11. IF :1.545
———————————————————————————————————————————————————
Fischer MO, Daccache G, Lemoine S, Tavernier B, Compère V, Hulet C, Bouchakour CE, Canevet C, Gérard JL, Guittet L, Lorne E, Hanouz JL, Parienti JJ. The OPVI trial – perioperative hemodynamic optimization using the plethysmographic variability index in orthopedic surgery: study protocol for a multicenter randomized controlled trial. Trials. 2015 Nov 4;16:503. IF:1.731
———————————————————————————————————————————————————
Fournel I, Bourredjem A, Sauleau EA, Cottet V, Dejardin O, Bouvier AM, Launoy G, Bonithon-Kopp C. Small-area geographic and socioeconomic inequalities in colorectal tumour detection in France. Eur J Cancer Prev. 2015 Jun 10. [Epub ahead of print] IF:3.031
———————————————————————————————————————————————————
Franceschi S, Combes JD, Dalstein V, Caudroy S, Clifford G, Gheit T, Tommasino M, Clavel C, Lacau St Guily J, Birembaut P; Study of Natural History of Human Papillomavirus Infection and Precancerous Lesions in the Tonsils (SPLIT). Deep brush-based cytology in tonsils resected for benign diseases. Int J Cancer. 2015 Dec 15;137(12):2994-9. IF:5.085
———————————————————————————————————————————————————
Gatta G, Botta L, Sánchez MJ, Anderson LA, Pierannunzio D, Licitra L; EUROCARE Working Group. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. Eur J Cancer. 2015 Sep 6. pii: S0959-8049(15)00749-2. IF:5.417
———————————————————————————————————————————————————
Gautschi O, Milia J, Cabarrou B, Bluthgen MV, Besse B, Smit EF, Wolf J, Peters S, Früh M, Koeberle D, Oulkhouir Y, Schuler M, Curioni-Fontecedro A, Huret B, Kerjouan M, Michels S, Pall G, Rothschild S, Schmid-Bindert G, Scheffler M, Veillon R, Wannesson L, Diebold J, Zalcman G, Filleron T, Mazières J. Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort. J Thorac Oncol. 2015 Oct;10(10):1451-7. IF:5.282
———————————————————————————————————————————————————
Gilard-Pioc S, Abrahamowicz M, Mahboubi A, Bouvier AM, Dejardin O, Huszti E, Binquet C, Quantin C. Multi-state relative survival modelling of colorectal cancer progression and mortality. Cancer Epidemiol.2015 Mar 25. pii: S1877-7821(15)00072-7. IF:4.125
———————————————————————————————————————————————————
Girard N, Audigier-Valette C, Cortot AB, Mennecier B, Debieuvre D, Planchard D, Zalcman G, Moro-Sibilot D, Cadranel J, Barlési F. ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice? Expert Rev Anticancer Ther. 2015 Feb;15(2):225-33. IF:3.461
———————————————————————————————————————————————————
Godin A, Renouf V, Raginel T. [Use of health professional cards by general practice locums: frequency and difficulties].[Article in French] Sante Publique. 2015 Jan-Feb;27(1):39-48.
———————————————————————————————————————————————————
Grangé S, Bekri S, Artaud-Macari E, Francois A, Girault C, Poitou AL, Benhamou Y, Vianey-Saban C, Benoist JF, Châtelet V, Tamion F, Guerrot D. Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency. Lancet. 2015 Sep 5;386(9997):1011-2.
———————————————————————————————————————————————————
Gravis G, Chanez B, Derosa L, Beuselinck B, Barthelemy P, Laguerre B, Brachet PE, Joly F, Escudier B, Harrison DJ, Laird A, Vasudev N, Ralph C, Larkin J, Lote H, Salem N, Walz J, Thomassin J, Sfumato P, Stewart GD, Boher JM; Renal Cross Channel Group. Effect of glandular metastases on overall survival of patients with metastatic clear cell renal cell carcinoma in the antiangiogenic therapy era. Urol Oncol. 2015 Dec 3. pii: S1078-1439(15)00526-8. IF:2.768
———————————————————————————————————————————————————
Guillaume E, Pornet C, Dejardin O, Launay L, Lillini R, Vercelli M, Marí-Dell’Olmo M, Fernández Fontelo A, Borrell C, Ribeiro AI, Pina MF, Mayer A, Delpierre C, Rachet B, Launoy G. Development of a cross-cultural deprivation index in five European countries. J Epidemiol Community Health. 2016 May;70(5):493-9.IF:3.501
———————————————————————————————————————————————————
Hecquet E, Bonamy C, Levesque C, Béchade C, Ficheux M, Lobbedez T. [Peritoneal dialysis catheter insertion under TAP block procedure: A pilot study]. [Article in French] Nephrol Ther. 2015 Jun;11(3):164-8. IF:2.083
———————————————————————————————————————————————————
Heyndrickx M, Le Rochais JP, Icard P, Cantat O, Zalcman G. Do atmospheric conditions influence the first episode of primary spontaneous pneumothorax? Interact Cardiovasc Thorac Surg. 2015 Sep;21(3):296-300. IF :1.155
———————————————————————————————————————————————————
Holleczek B, Rossi S, Domenic A, Innos K, Minicozzi P, Francisci S, Hackl M, Eisemann N, Brenner H; EUROCARE-5 Working Group. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 – Results from the EUROCARE-5 study. Eur J Cancer. 2015 Sep 6. pii: S0959-8049(15)00704-2. IF:5.417
———————————————————————————————————————————————————
Hovhannisyan N, Guillouet S, Fillesoye F, Dhilly M, Patin D, Galateau F, Leporrier M, Barré L. Evaluation of the specificity of [(18)F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [(18)F]FDG and impact of rituximab therapy. EJNMMI Res. 2015 Apr 14;5:23. IF:5.383
———————————————————————————————————————————————————
Jégu J, Belot A, Borel C, Daubisse-Marliac L, Trétarre B, Ganry O, Guizard AV, Bara S, Troussard X, Bouvier V, Woronoff AS, Colonna M, Velten M. Effect of previous history of cancer on survival of patients with a second cancer of the head and neck. Oral Oncol. 2015 Feb 13. IF:3.607
———————————————————————————————————————————————————
Joly F, Delva R, Mourey L, Sevin E, Bompas E, Vedrine L, Ravaud A, Eymard JC, Tubiana-Mathieu N, Linassier C, Houede N, Guillot A, Ringensen F, Cojocarasu O, Valenza B, Leconte A, Lheureux S, Clarisse B, Oudard S. Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study. BJU Int. 2015 Jan;115(1):65-73. IF:3.533
———————————————————————————————————————————————————
Joly F, Giffard B, Rigal O, De Ruiter MB, Small BJ, Dubois M, LeFel J, Schagen SB, Ahles TA, Wefel JS, Vardy JL, Pancré V, Lange M, Castel H. Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012. J Pain Symptom Manage. 2015 Dec;50(6):830-41. IF:2.795
———————————————————————————————————————————————————
Joubert M, Fourmy C, Henri P, Ficheux M, Lobbedez T, Reznik Y. Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study. Diabetes Res Clin Pract. 2015 Mar;107(3):348-54 IF:2.538
———————————————————————————————————————————————————
Hovhannisyan N, Guillouet S, Fillesoye F, Dhilly M, Patin D, Galateau F, Leporrier M, Barré L. Evaluation of the specificity of [(18)F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [(18)F]FDG and impact of rituximab therapy. EJNMMI Res. 2015 Apr 14;5:23. IF:3.028
———————————————————————————————————————————————————
Lamotte G, Morello R, Lebasnier A, Agostini D, Defer GL. Accuracy and cutoff values of delayed heart to mediastinum ratio with (123) I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses. BMC Neurol. 2015 May 15;15:83. IF:2.04
———————————————————————————————————————————————————
Landreau P, Drouillard A, Launoy G, Ortega-Deballon P, Jooste V, Lepage C, Faivre J, Facy O, Bouvier AM. Incidence and survival in late liver metastases of colorectal cancer. J Gastroenterol Hepatol. 2015 Jan;30(1):82-5. IF:3.504
———————————————————————————————————————————————————
Lange M, Heutte N, Morel N, Eustache F, Joly F, Giffard B. Cognitive complaints in cancer: The French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), normative data from a healthy population. Neuropsychol Rehabil. 2015 May 7:1-18. IF:1.955
———————————————————————————————————————————————————
Lantuejoul S, Rouquette I, Blons H, Le Stang N, Ilie M, Begueret H, Grégoire V, Hofman P, Gros A, Garcia S, Monhoven N, Devouassoux-Shisheboran M, Mansuet-Lupo A, Thivolet F, Antoine M, Vignaud JM, Penault-Llorca F, Galateau-Sallé F, McLeer-Florin A. French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas. Eur Respir J. 2015 Jul;46(1):207-18. IF:7.636
———————————————————————————————————————————————————
Lebailly P, Mirey G, Herin F, Lecluse Y, Salles B, Boutet-Robinet E. DNA damage in B and T lymphocytes of farmers during one pesticide spraying season. Int Arch Occup Environ Health. 2015 Feb 3. IF:2.196
———————————————————————————————————————————————————
Lecerf M, Vardon D, Morello R, Lamendour N, Dreyfus M. [Comparison of diagnostic performance of two tests of premature rupture of membranes (IGFBP-1/PAMG-1) in clinical practice.] J Gynecol Obstet Biol Reprod (Paris). 2015 Jan 28. IF:0.563
———————————————————————————————————————————————————
Lecluse Y, Comby E, Mariotte D, Tual S, Le Mauff B, Lebailly P, Gauduchon P. Prevalence of monoclonal gammopathy of undetermined significance (MGUS) among farmers involved in open field farming and/or cattle breading in France. Leuk Lymphoma. 2015 Dec 21:1-4. [Epub ahead of print] IF: 2.891
———————————————————————————————————————————————————
Lecoq B, Hanouz N, Morello R, Jean-Jacques PY, Dutheil JJ, Hulet C, Marcelli C. Ultrasound-assisted surgical release of carpal tunnel syndrome: Results of a pilot open-label uncontrolled trial conducted outside the operating theatre. Joint Bone Spine. 2015 Apr 13. pii: S1297-319X(15)00067-6. IF:2.901
———————————————————————————————————————————————————
Le Loarer F, Watson S, Pierron G, de Montpreville VT, Ballet S, Firmin N, Auguste A, Pissaloux D, Boyault S, Paindavoine S, Dechelotte PJ, Besse B, Vignaud JM, Brevet M, Fadel E, Richer W, Treilleux I, Masliah-Planchon J, Devouassoux-Shisheboran M, Zalcman G, Allory Y, Bourdeaut F, Thivolet-Bejui F, Ranchere-Vince D, Girard N, Lantuejoul S, Galateau-Sallé F, Coindre JM, Leary A, Delattre O, Blay JY, Tirode F. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas. Nat Genet. 2015 Oct;47(10):1200-5. IF: 29.352
———————————————————————————————————————————————————
Le Monnier A, Duburcq A, Zahar JR, Corvec S, Guillard T, Cattoir V, Woerther PL, Fihman V, Lalande V, Jacquier H, Mizrahi A, Farfour E, Morand P, Marcadé G, Coulomb S, Torreton E, Fagnani F, Barbut F; GMC Study Group. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals. J Hosp Infect. 2015 Oct;91(2):117-22. IF:2.544
———————————————————————————————————————————————————
Lepage C, Capocaccia R, Hackl M, Lemmens V, Molina E, Pierannunzio D, Sant M, Trama A, Faivre J; EUROCARE-5 Working Grouph. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5. Eur J Cancer. 2015 Sep 5. pii: S0959-8049(15)00714-5. IF:5.417
———————————————————————————————————————————————————
Le Péchoux C, Dunant A, Faivre-Finn C, Thomas PA, Pourel N, Lerouge D, Edwards J, Van Schil P, Rami-Porta R, Dansin E, Nestle U, Fadel E, Zalcman G. Postoperative Radiotherapy for Pathologic N2 Non-Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: Need for Randomized Evidence. J Clin Oncol. 2015 Sep 10;33(26):2930-1. IF:18.428
———————————————————————————————————————————————————
Levêque-Morlais N, Tual S, Clin B, Adjemian A, Baldi I, Lebailly P. The AGRIculture and CANcer (AGRICAN) cohort study: enrollment and causes of death for the 2005-2009 period. Int Arch Occup Environ Health. 2015 Jan;88(1):61-73. IF:2.196
———————————————————————————————————————————————————
Lheureux S, N’Diaye M, Blanc-Fournier C, Dugué AE, Clarisse B, Dutoit S, Giffard F, Abeilard E, Briand M, Labiche A, Grellard JM, Crouet H, Martin S, Joly F, Poulain L. Identification of predictive factors of response to the BH3-mimetic molecule ABT-737: an ex vivo experiment in human serous ovarian carcinoma. Int J Cancer. 2015 Mar 1;136(5):E340-50. IF:5.085
———————————————————————————————————————————————————
Marcos-Gragera R, Mallone S, Kiemeney LA, Vilardell L, Malats N, Allory Y, Sant M; EUROCARE-5 Working Group. Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5. Eur J Cancer. 2015 Sep 5. pii: S0959-8049(15)00708-X. IF:5.417
———————————————————————————————————————————————————
Martin M, Lubrano J, Azizi A, Paquette B, Badet N, Delabrousse E. Inflammatory appendix mass in patients with acute appendicitis: CT diagnosis and clinical relevance. Emerg Radiol. 2015 Feb;22(1):7-12.
———————————————————————————————————————————————————
Mathieu R, Pignot G, Ingles A, Crepel M, Bigot P, Bernhard JC, Joly F, Guy L, Ravaud A, Azzouzi AR, Gravis G, Chevreau C, Zini L, Lang H, Pfister C, Lechevallier E, Fais PO, Berger J, Vayleux B, Roupret M, Audenet F, Descazeaud A, Rigaud J, Machiels JP, Staehler M, Salomon L, Ferriere JM, Kleinclauss F, Bensalah K, Patard JJ. Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features. Urol Oncol. 2015 Aug;33(8):339.e9-15. IF:2.768
———————————————————————————————————————————————————
Mazières J, Zalcman G, Crinò L, Biondani P, Barlesi F, Filleron T, Dingemans AM, Léna H, Monnet I, Rothschild SI, Cappuzzo F, Besse B, Thiberville L, Rouvière D, Dziadziuszko R, Smit EF, Wolf J, Spirig C, Pecuchet N, Leenders F, Heuckmann JM, Diebold J, Milia JD, Thomas RK, Gautschi O. Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort. J Clin Oncol. 2015 Feb 9. IF:18.428
———————————————————————————————————————————————————
Menahem B, Mulliri A, Bazille C, Salame E, Morello R, Alves A, Chiche L, Lubrano J. Body Surface Area: A New Predictive Factor of Mortality and Pancreatic Fistula After Pancreaticoduodenectomy: A cohort-study. Int J Surg. 2015 Mar 27. pii: S1743-9191(15)00100-4. IF:1.531
———————————————————————————————————————————————————
Menahem B, Lubrano J, Desjouis A, Lepennec V, Lebreton G, Alves A. Transjugular intrahepatic portosystemic shunt placement increases feasibility of colorectal surgery in cirrhotic patients with severe portal hypertension. Dig Liver Dis. 2015 Jan;47(1):81-4. IF:2.963
———————————————————————————————————————————————————
Menahem B, Guittet L, Mulliri A, Alves A, Lubrano J. Pancreaticogastrostomy Is Superior to Pancreaticojejunostomy for Prevention of Pancreatic Fistula After Pancreaticoduodenectomy: An Updated Meta-analysis of Randomized Controlled Trials. Ann Surg. 2015 May;261(5):882-7.IF:8.327
———————————————————————————————————————————————————
Menahem B, Mulliri A, Fohlen A, Guittet L, Alves A, Lubrano J. Delayed laparoscopic cholecystectomy increases the total hospital stay compared to an early laparoscopic cholecystectomy after acute cholecystitis: an updated meta-analysis of randomized controlled trials. HPB (Oxford). 2015 Oct;17(10):857-62. IF:2.675
———————————————————————————————————————————————————
Morel N, Dayan J, Piolino P, Viard A, Allouache D, Noal S, Levy C, Joly F, Eustache F, Giffard B. Emotional specificities of autobiographical memory after breast cancer diagnosis. Conscious Cogn. 2015 Sep;35:42-52. IF:2.31
———————————————————————————————————————————————————
Moro-Sibilot D, Audigier-Valette C, Merle P, Quoix E, Souquet PJ, Barlesi F, Chouaid C, Molinier O, Bennouna J, Lavolé A, Mazières J, Toffart AC, Langlais A, Morin F, Zalcman G. Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study). Lung Cancer. 2015 Aug;89(2):139-45.
———————————————————————————————————————————————————
Mortamet G, Morello R, Jokic M, Vabret A, Leroux M, Brouard J, Dina J. [Winter viral ecology in a pediatric intensive care unit: a prospective study]. [Article in French] Arch Pediatr. 2015 Apr;22(4):368-72. IF:0.407
———————————————————————————————————————————————————
Moutel G. [The wishes and autonomy of the patient faced with a care decision]. [Article in French] Soins. 2015 Jun;(796):43-5.
———————————————————————————————————————————————————
Moutel G. [Foundations and construction of the ethical approach in nursing practice]. [Article in French] Soins. 2015 Dec;(801):28-32.
———————————————————————————————————————————————————
Muller J, Grosclaude P, Lapôtre-Ledoux B, Woronoff AS, Guizard AV, Bara S, Colonna M, Troussard X, Bouvier V, Trétarre B, Velten M, Jégu J. Trends of the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10,047 patients. BJU Int. 2015 Oct 15. doi: 10.1111/bju.13351. [Epub ahead of print] IF:3.533
———————————————————————————————————————————————————
Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon TW, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, Swart AM, Farrelly L, Kaplan R, Parmar MK, Perren TJ; ICON7 trial investigators. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncol. 2015 Aug;16(8):928-36. IF:24.69
———————————————————————————————————————————————————
Parazols F, Fournier L, Bouvier N, Pelage JP, Lobbedez T, Hurault de Ligny B. [Renal lymphangiectasia, a rare case of perirenal infiltration]. [Article in French] Nephrol Ther. 2015 Apr;11(2):118-20. IF:2.083
———————————————————————————————————————————————————
Patron V, Roger V, Moreau S, Babin E, Hitier M. State of the art of endoscopic frontal sinus cerebrospinal fluid leak repair. Eur Ann Otorhinolaryngol Head Neck Dis. 2015 Dec;132(6):347-52. IF:0.822
———————————————————————————————————————————————————
Pearce NE, Blair A, Vineis P, Ahrens W, Andersen A, Anto JM, Armstrong BK, Baccarelli AA, Beland FA, Berrington A, Bertazzi PA, Birnbaum LS, Brownson RC, Bucher JR, Cantor KP, Cardis E, Cherrie JW, Christiani DC, Cocco P, Coggon D, Comba P, Demers PA, Dement JM, Douwes J, Eisen EA, Engel LS, Fenske RA, Fleming LE, Fletcher T, Fontham E, Forastiere F, Frentzel-Beyme R, Fritschi L, Gerin M, Goldberg M, Grandjean P, Grimsrud TK, Gustavsson P, Haines A, Hartge P, Hansen J, Hauptmann M, Heederik D, Hemminki K, Hemon D, Hertz-Picciotto I, Hoppin JA, Huff J, Jarvholm B, Kang D, Karagas MR, Kjaerheim K, Kjuus H, Kogevinas M, Kriebel D, Kristensen P, Kromhout H, Laden F, Lebailly P, LeMasters G, Lubin JH, Lynch CF, Lynge E, ‘t Mannetje A, McMichael AJ, McLaughlin JR, Marrett L, Martuzzi M, Merchant JA, Merler E, Merletti F, Miller A, Mirer FE, Monson R, Nordby KK, Olshan AF, Parent ME, Perera FP, Perry MJ, Pesatori AC, Pirastu R, Porta M, Pukkala E, Rice C, Richardson DB, Ritter L, Ritz B, Ronckers CM, Rushton L, Rusiecki JA, Rusyn I, Samet JM, Sandler DP, de Sanjose S, Schernhammer E, Seniori Constantini A, Seixas N, Shy C, Siemiatycki J, Silvermann DT, Simonato L, Smith AH, Smith MT, Spinelli JJ, Spitz MR, Stallones L, Stayner LT, Steenland K, Stenzel M, Stewart BW, Stewart PA, Symanski E, Terracini B, Tolbert PE, Vainio H, Vena J, Vermeulen R, Victora CG, Ward EM, Weinberg CR, Weisenburger D, Wesseling C, Weiderpass E, Zahm SH. IARC Monographs: 40 Years of Evaluating Carcinogenic Hazards to Humans. Environ Health Perspect. 2015 Feb 24. IF:7.977
———————————————————————————————————————————————————
Picard HL, Latreche S, Thurairajasingam N, Auzan C, Fiquet B, Frayssinet R, Garnier A, Jendruchova V, Lobbedez T, Martorell L, Mortier G, Pela I, Taque S, Vargas-Poussou R, Clauser E, Jeunemaitre X. 6C.01: CULLIN-3 MUTATIONS LEADING TO SKIPPING OF EXON 9 ARE RESPONSIBLE FOR SEVERE CASES OF FAMILIAL HYPERKALAEMIC HYPERTENSION. J Hypertens. 2015 Jun;33 Suppl 1:e79. IF:4.72
———————————————————————————————————————————————————
Pujol JL, Lavole A, Quoix E, Molinier O, Souquet PJ, Barlesi F, Le Caer H, Moro-Sibilot D, Fournel P, Oster JP, Chatellain P, Barre P, Jeannin G, Mourlanette P, Derollez M, Herman D, Renault A, Dayen C, Lamy PJ, Langlais A, Morin F, Zalcman G; French Cooperative Thoracic Intergroup (IFCT). Randomized Phase II-III Study of Bevacizumab in Combination with Chemotherapy in Previously Untreated Extensive Small-Cell Lung Cancer: Results from the IFCT-0802 Trial. Ann Oncol. 2015 Feb 16. IF:7.04
———————————————————————————————————————————————————
Radoï L, Menvielle G, Cyr D, Lapôtre-Ledoux B, Stücker I, Luce D; ICARE Study Group. Population attributable risks of oral cavity cancer to behavioral and medical risk factors in France: results of a large population-based case-control study, the ICARE study. BMC Cancer. 2015 Oct 31;15:827. IF:3.362
———————————————————————————————————————————————————
Rami-Porta R, Bolejack V, Crowley J, Ball D, Kim J, Lyons G, Rice T, Suzuki K, Thomas CF Jr, Travis WD, Wu YL; IASLC Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions. The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2015 Jul;10(7):990-1003. IF:5.282
———————————————————————————————————————————————————
Riffaut N, Lobbedez T, Hazzan M, Bertrand D, Westeel PF, Launoy G, Danneville I, Bouvier N, Hurault de Ligny B. Access to preemptive registration on the waiting list for renal transplantation: a hierarchical modeling approach. Transpl Int. 2015 Sep;28(9):1066-73. IF:2.599
———————————————————————————————————————————————————
Rizvi NA, Mazières J, Planchard D, Stinchcombe TE, Dy GK, Antonia SJ, Horn L, Lena H, Minenza E, Mennecier B, Otterson GA, Campos LT, Gandara DR, Levy BP, Nair SG, Zalcman G, Wolf J, Souquet PJ, Baldini E, Cappuzzo F, Chouaid C, Dowlati A, Sanborn R, Lopez-Chavez A, Grohe C, Huber RM, Harbison CT, Baudelet C, Lestini BJ, Ramalingam SS. . Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Lancet Oncol. 2015 Feb 19. pii: S1470-2045(15)70054-9. IF:24.69
———————————————————————————————————————————————————
Rossi C, Jégu J, Mounier M, Dandoit M, Colonna M, Daubisse-Marliac L, Trétarre B, Ganry O, Guizard AV, Bara S, Bouvier V, Woronoff AS, Monnereau A, Casasnovas O, Velten M, Troussard X, Maynadié M. Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma. Leuk Lymphoma. 2015 Feb 2:1-23. IF:2.891
———————————————————————————————————————————————————
Rossi S, Baili P, Capocaccia R, Caldora M, Carrani E, Minicozzi P, Pierannunzio D, Santaquilani M, Trama A, Allemani C, Belot A, Buzzoni C, Lorez M, De Angelis R; EUROCARE-5 Working Group. The EUROCARE-5 study on cancer survival in Europe 1999-2007: database, quality checks and statistical analysis methods. Eur J Cancer. 2015 Sep 6. pii: S0959-8049(15)00776-5. IF:5.417
———————————————————————————————————————————————————
Ryan CJ, Smith MR, Fizazi K, Saad F, Mulders PF, Sternberg CN, Miller K, Logothetis CJ, Shore ND, Small EJ, Carles J, Flaig TW, Taplin ME, Higano CS, de Souza P, de Bono JS, Griffin TW, De Porre P, Yu MK, Park YC, Li J, Kheoh T, Naini V, Molina A, Rathkopf DE; COU-AA-302 Investigators. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. Lancet Oncol. 2015 Feb;16(2):152-60. IF:24.69
———————————————————————————————————————————————————
Saad F, Fizazi K, Jinga V, Efstathiou E, Fong PC, Hart LL, Jones R, McDermott R, Wirth M, Suzuki K, MacLean DB, Wang L, Akaza H, Nelson J, Scher HI, Dreicer R, Webb IJ, de Wit R; ELM-PC 4 investigators. Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial. Lancet Oncol. 2015 Mar;16(3):338-48. IF:24.69
———————————————————————————————————————————————————
Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M, Dimitrova N, Innos K, Katalinic A, Langseth H, Larrañaga N, Rossi S, Siesling S, Minicozzi P; EUROCARE-5 Working Group. Survival of women with cancers of breast and genital organs in Europe 1999-2007: results of the EUROCARE-5 study. Eur J Cancer. 2015 Sep 6. pii: S0959-8049(15)00702-9. IF:5.417
———————————————————————————————————————————————————
Soria JC, Felip E, Cobo M, Lu S, Syrigos K, Lee KH, Göker E, Georgoulias V, Li W, Isla D, Guclu SZ, Morabito A, Min YJ, Ardizzoni A, Gadgeel SM, Wang B, Chand VK, Goss GD; LUX-Lung 8 Investigators. Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial. Lancet Oncol. 2015 Aug;16(8):897-907. IF:24.69
———————————————————————————————————————————————————
Sternberg CN, Skoneczna I, Kerst JM, Albers P, Fossa SD, Agerbaek M, Dumez H, de Santis M, Théodore C, Leahy MG, Chester JD, Verbaeys A, Daugaard G, Wood L, Witjes JA, de Wit R, Geoffrois L, Sengelov L, Thalmann G, Charpentier D, Rolland F, Mignot L, Sundar S, Symonds P, Graham J, Joly F, Marreaud S, Collette L, Sylvester R; European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group; Groupe d’Etude des Tumeurs Urogénitales; National Cancer Research Institute Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; German Association of Urologic Oncology. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial. Lancet Oncol. 2015 Jan;16(1):76-86. IF:24.69
———————————————————————————————————————————————————
Taupin A, Labbé D, Babin E, Fromager G. Facial reanimation by muscle-nerve neurotization after facial nerve sacrifice. Case report. Ann Chir Plast Esthet. 2015 Sep 21. pii: S0294-1260(15)00132-6. IF:0.306
———————————————————————————————————————————————————
Trama A, Foschi R, Larrañaga N, Sant M, Fuentes-Raspall R, Serraino D, Tavilla A, Van Eycken L, Nicolai N; EUROCARE-5 Working Group. Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study. Eur J Cancer. 2015 Sep 6. pii: S0959-8049(15)00707-8. IF:5.417
———————————————————————————————————————————————————
Trétarre B, Molinié F, Woronoff AS, Bossard N, Bessaoud F, Marrer E, Grosclaude P, Guizard AV, Delafosse P, Bara S, Velten M, Lapôtre-Ledoux B, Ligier K, Léone N, Arveux P, Uhry Z. Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012. Gynecol Oncol. 2015 Nov;139(2):324-9. IF:3.774
———————————————————————————————————————————————————
Tripey V, Monsallier JM, Morello R, Hamel-Desnos C. French sclerotherapy and compression: Practice patterns. Phlebology. 2015 Oct;30(9):632-40. IF:1.774
———————————————————————————————————————————————————
Veracini L, Grall D, Schaub S, Beghelli-de la Forest Divonne S, Etienne-Grimaldi MC, Milano G, Bozec A, Babin E, Sudaka A, Thariat J, Van Obberghen-Schilling E. Elevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas. Oncotarget. 2015 Apr 10;6(10):7570-83. IF:6.359
———————————————————————————————————————————————————
Vignot S, Zalcman G. [Molecular targeted therapies and cytotoxics: Friends or foes?]. [Article in French] Bull Cancer. 2015 Jun;102(6 Suppl 1):S91-2. IF:0.604
———————————————————————————————————————————————————
Villot A, Cheret-Benoist A, Creveuil C, Turck M, Dreyfus M, Benoist G. [Is vaginal delivery possible for patients with myomectomy? Results of a monocentric study]. [Article in French] Gynecol Obstet Fertil. 2015 Jul-Aug;43(7-8):496-501. IF:0.522
———————————————————————————————————————————————————
Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P; EUROCARE-5 Working Group. Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study. Eur J Cancer. 2015 Sep 5. pii: S0959-8049(15)00712-1. IF:5.417
———————————————————————————————————————————————————
Zalcman G, Federman N, de la Fuente V, Romano A. Nuclear factor kappa B-dependent Zif268 expression in hippocampus is required for recognition memory in mice. Neurobiol Learn Mem. 2015 Jan 7;119C:10-17.
